<--- Back to Details
First PageDocument Content
Glucocorticoids / Lenalidomide / Cancer research / Multiple myeloma / Celgene / Thalidomide / International Myeloma Foundation / Dexamethasone / Bortezomib / Medicine / Chemistry / Immunosuppressants
Date: 2012-04-18 11:52:53
Glucocorticoids
Lenalidomide
Cancer research
Multiple myeloma
Celgene
Thalidomide
International Myeloma Foundation
Dexamethasone
Bortezomib
Medicine
Chemistry
Immunosuppressants

CITINGS CELGENE THALIDOMIDE and REVLIMID™ ASH 2004

Add to Reading List

Source URL: myeloma.org

Download Document from Source Website

File Size: 152,13 KB

Share Document on Facebook

Similar Documents

Celgene Blue-EPS- NEW.eps

DocID: 1tXF2 - View Document

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use REVLIMID® safely and effectively. See full prescribing information for REVLIMID. REVLIMID [lenalidomide] capsules,

DocID: 1tonS - View Document

Celgene IncMississauga Road Suite 600 Mississauga, ON L5N 7Y2 Tel: Toll-free:

DocID: 1thuA - View Document

Celgene IncMississauga Road Suite 600 Mississauga, ON L5N 7Y2 Tel: Toll-free:

DocID: 1tgVI - View Document

Celgene IncMississauga Road Suite 600 Mississauga, ON L5N 7Y2 Tél. : Sans frais :

DocID: 1t2Vj - View Document